Spine device study pulled before it began

NCT ID NCT05944081

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study was designed to check how well the Arcadius XP L spine fusion device works and if it is safe for people with chronic low-back pain from conditions like degenerative disc disease or instability. The plan was to follow 60 patients for at least one year after surgery. However, the study was withdrawn before any patients were enrolled, so no new data was collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Arcadius XP L interbody fusion device

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intervertebral disk degenerative disorder lumbar disk degenerative disorder spondylolisthesis spondylolysis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medius Klinik Nürtingen

    Nürtingen, Baden-Wurttemberg, 72622, Germany

  • Rems-Murr-Klinik Schorndorf

    Schorndorf, Baden-Wurttemberg, 73614, Germany

  • Schelztor-Klinik Esslingen

    Esslingen am Neckar, Baden-Wurttemberg, 73728, Germany